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CH APTER 1. REVIEW OF LITERATU RE 
The uterine artery is a major source of blood supply to the uterus. The other 
two arteries supplying the uterus are the ovarian and vaginal arteries . The uterine 
artery arises from the umbilical artery, which originates from the internal iliac artery 
[28]. 
The walls of the arteries supplying the uterus are composed of three layers: the 
tunica intima, the tunica media, and the tunica adventitia [71]. The tunica intima 
is the innermost layer, consisting of a single layer of endothelial cells attached to the 
basement membrane. Endothelial cells are flat and elongated cells with a thickness 
of about 0.1-0.2 µm. The endothelial cells are held together by junctional complexes. 
The tunica media is the middle layer of the vascular wall, and is composed largely of 
spindle shaped smooth muscle cells with a fine collagen and elastic network between 
them. A thick internal elastic lamina separates the tunica media and tunica intima. 
This internal elastic lamina is about 3µm in thickness and is fenest rated , which facil-
itates metabolic and diffusion processes in order to establish a membranous contact 
with smooth muscle cells of the tunica media. Longitudinally arranged smooth mus-
cle cells are present in the region of the internal elastic lamina. Tunica adventitia, 
the outermost layer , is composed of dense fibro elastic tissue without smooth muscle 
cells. The adventitia gives rigidity to the vascular wall and connects blood vessels to 
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the surrounding tissues [71 ]. Adventitia is the site where vasomotor neurons course 
before terminating on the vascular smooth muscle cells. 
The adrenergic innervation of most blood vessels is not uniform in density but 
is limited to the adventitiomedial junction as a continuous plexus surrounding the 
smooth muscle of the media [9]. This is supported by t he results obtained in the 
rabbit saphenous artery, where the distribution of adrenergic plexus is not uniform 
along the length of the artery [7]. Thus, variation in the distri bu ti on of adrenergic 
innervation along the artery might lead to differences in the responses to sympathetic 
stimulation. 
Blood flow to the reproductive t ract is undel' the influence of sympathet ic vaso-
constrictor nerves [48]. The main sympathetic perivascular plexus surrounding the 
uterine arterial vessels are post ganglioinic 'fibers deri ved from the abdominal aortic 
plexus via the iliac plexus. The uterine artery receives additional sympathetic inner-
vation from the utero-vaginal plexus [78]. Vasoconstriction mediated by a-adrenergic 
receptors predominates in the vessels of the uterus and ovaries . a-Adrenergic ago-
nists such as phenylephrine, and norepinephrine are effective constrictors of human 
[17], ovine [39], and porcine [82] uterine vasculature. 
The estrous cycle in the pig lasts approximately 21 days and is divided into 
the follicular phase and the luteal phase [80]. During this period blood flow to 
the uterus fluctuates, and this has been correlated with the ratio of estrogen and 
progesterone in the systemic blood [22]. Similar observations have been made in the 
ewe [31] and cow [21]. Estrogen has been reported to increase blood flow to the 
porcine uterus. On the other hand, progesterone has been reported to antagonize 
the effect of estrogen [69]. Ford et al. indicated that during the estrous cycle of gilts 
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the steroid hormone progesterone of endogenous or exogenous ongm mcreases the 
number of 0:1-adrenergic receptor number on uterine smooth muscle cells [23]. The 
phasic contractility of pig uterine artery has also been reported to be influenced by 
estrogen and progesterone. Uterine arterial contractility in gilts was higher during the 
luteal phase (high progesterone / low est rogen) of the estrous cycle and lower during 
the follicular phase (low progesterone / high eshogen) [23]. Furthermore, McKercher 
et al. [52] observed a reduction in. norepinephrine content of uterine periarterial 
sympathetic nerves in estrogen treated rats. It has been suggested that estrogen 
decreases and progesterone increases the function of the periarterial sympathetic 
nerves. 
Responsiveness of uterine arteries to adrenergic receptor agonists such as phenyle-
phrine and norepinephrine has been reported to be different between non pregnant and 
pregnant gilts [23]. A number of studies has indicated that pregnancy is associated 
with specific alterations of systemic vascular reactivity [13] & [14]. Ford et al. [23] 
reported that contractile responses of uterine artery to adrenergic receptor agonists 
is different during the estrous cycle in gilts. A variation in the adrenergic innervation 
in the rat uterus during the estrous cycle has been reported by Adham and Schenk 
[1]. Also there have been reports indicating a reduction in the adrenergic fibers in 
the dog [74] uterus by the end of the pregnancy. A similar reduction of adrenergic 
nerve terminals has been reported in pregnant guinea pig [79] and rabbit [72] uterus . 
During the 114days gestation in the pig, the uterine arterial diameter has been 
reported to increase from 4.5±.6 mm on day 0 to 9±.1 mm on day 110 [32]. This 
change in arterial diameter has been attributed to a decline in the ratio of collagen 
to elastin throughout gestation. Similar results have been obtained in the guinea pig 
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where an increased diameter of arteries supplying the uterine tissues during pregnancy 
was correlated to changes in the nonmuscular element of the arterial wall and this 
effect was mediated by estrogen [55]. Collagen and elastin make up over one half of 
the dry weight of the arterial wall [20]. 
The neurotransmitter norepinephrine is synthesized, stored in and released from 
adrenergic nerve terminals. Norepinephrine is synthesized from its precursor , tyro-
sine, which is generally available in body fluids and is converted in the neuron to 3 4-
dihydroxyphenylalanine (dopa) by tyrosine hydroxylase. Tyrosine hydroxylase an 
important regulatory enzyme in the biosynthesis of norepinephrine, is present in the 
nerve. axoplasm. Dopa decarboxylase, a nonspecific enzyme present in the cytosol, 
then converts dopa to dopamine. Dopamine is then converted to norepinephrine by 
dopamine ,8-hydroxylase, an enzyme closely as~ociated with the norepinephrine stor-
age granules. Norepinephrine is stored in a large number of dense core vesicles known 
as varicosities [50]. 
Upon nerve stimulation norepinephrine is released by exocytosis into the synaptic 
cleft. The released norepinephrine can then reach adrenergic receptor by diffusion and 
thereby produce its effect. Norepinephrine induces contraction of smooth muscle by 
interacting with membrane bound a-adrenergic receptors. After the release of nore-
pinephrine from the terminal into the synaptic cleft , it is inactivated by speciali zed 
t ransport sys tems that mediate either reuptake of the released norepinephrine into 
the nerve terminals (neuronal uptake or uptake-1 ), or uptake into the non-neuronal 
sites (extraneuronal uptake or uptake-2 ). The two metabolic enzymes catechol-0-
methyltransferase (CO.MT ) and monoamine oxidase ( ~1AO ) also play an important 
role in the disposition of norepinephrine. :'f euronal uptake involves the tran ::. port of 
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norepinephrine from the extracellular fluid across the neuronal membrane. On the 
other hand, extraneuronal uptake involves the influx of norepinephrine across cellular 
membrane other than those .of neurons [10]. thus, the above mentioned processes (i. 
e., uptake-1, uptake-2 , and metabolizing enzymes MAO & COMT) play a principal 
role in terminating the action of norepinephrine. 
The two uptake processes, i.e., uptake-1 and uptake-2, involved in transporting 
norepinephrine differ in terms of their sodium dependency. Neuronal uptake is an ac-
tive process and is absolutely dependent on the presence of sodium and chloride. The 
carrier involved in transporting norepinephrine across the neuronal membrane has 
three binding sites, one for sodium, one for chloride , and one for t_he norepinephrine. 
This carrier is mobile when all three binding sites are free but the binding of sodium 
to the carrier makes it immobile. The carrier regains its mobility as soon as chlo-
ride and norepinephrine binds to it [87]. The second uptake process ( uptake-2) or 
extraneuronal uptake is not dependent on the presence of sodium and chloride [86]. 
Monoamine oxidase is a flavoprotein, which is localized in the mitochondria. It 
has been reported to be present in sympathetic neurons as ~ell as in other adjacent 
cells [92]. Whereas , COMT has been reported to be present predominantly in the 
smooth muscle cells [90]. This differential localization of MAO and COMT is sup-
ported by experiments in which after sympathetic denervation the COMT activity 
of various tissues was unchanged. Monoamine oxidase activity was reduced but not 
abolished by sympathetic denervation [40]. 
Raab and Gigee [68], Nickerson and colleagues [62], were the first to demon-
st rate an increase in catecholamine content of cat, dog , and rat hearts after the 
administration of large doses of epinephrine and norepinephrine. Strombland and 
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Nickerson [ 3] found in their experiments that the rat heart and salivary gland could 
accumulate norepinephrine or epinephrine after in vivo or in vitro administration of 
catecholamines. From these results they concluded that this uptake by tissues, which 
is related to the sympathetic nerve ending (neuronal uptake), is a major factor in 
terminating the effect of catecholamines. Iversen [41], while working on isolated rat 
heart , suggested that catecholamines are taken up not only in neuronal cells but 
also by extraneuronal cells e.g. , myocardial cells of the heart. When catecholamine 
concentration is low , there is no accumulation of norepinephrine inside the extraneu-
ronal cells as it is metabolized by the enzymes MAO and COMT. Thus, deamination 
and 0-methylation of catecholamines caused by MAO and COMT, respectively, are 
subsequent to uptake processes [86]. 
The route of disposition of catecholamines (norepinephrine) varies from vessel 
to vessel and depends on the width of the synaptic cleft as well as on the thickness 
of the vessel [10]. The nerve-muscle distance influences the concentration of the 
transmitter which can reach the postsynaptic receptor , and the different cell layers 
of the blood vessel wall [8]. In smaller blood vessels the nerve-muscle di stance is 
small; hence the effect of diffusion is negligible causing the transmitter concentration 
to be localized within the synaptic cleft. This leads to a rapid contractile effect 
since the a-adrenergic receptors are located at the postsynaptic membrane. Because 
of functional coupling between the smooth muscle cells the spread of the contractile 
response occurs by myogenic propagation [6]. In larger vessels, a-adrenergic receptors 
are present throughout the blood vessel wall and the synaptic cleft is usually wider. 
Thus, transmitter (norepinephrine) will diffuse throughout the surrounding tunica 
media, resul ting in a slow contractile response [6] . In vessels of intermediate size, 
nerve-muscle distance is neithe r too small nor too la rge. In vesse ls of intermediate 
size, the cont ractile response is a combination of fast response (due to the high 
concentration of norepinephrine at the postsynaptic membrane) followed by a slow 
contractile response (due to the diffusion of norepinephrine to a-adrenergic receptors 
throughout the wall) [6]. 
The inhibition of neuronal uptake by cocaine and other pharmacological agents 
[87] is used to· analyze the importance of uptake-1 in the disposition of exogenous and 
endogenous norepinephrine. Similarly, pharmacological blockade of extraneuronal 
uptake by corticosterone [ 6] and blockade of intracellular enzymes by tropolone 
(COMT inhibitor) and iproniazid ( ~IAO inhibitor ) [29] are used to assess the role of 
uptake-2, MAO & COMT in t ransmitter disposit ion. 
C lassification o f Adren ergic R eceptors 
The concept of specific receptors was first introduced by Langley [4 7] who in-
t roduced the term receptive substance and proposed t hat the receptive substance 
receives the s timuli from drugs which is then transferred to the effector organs. 
Ahlquist [3] proposed a division of adrenergic receptors into two major types: 
a- and ,8-adrenergic receptors. Studies have shown t hat there are two types of a-
adrenergic receptors, designated 0:1 - and 0:2-adrenergic receptors [46]. Further stud-
ies have shown t hat the a 1-, 0:2- and J -adrenergic receptors can each be further 
subdivided as shown in Figure 1.1. [12]. 
Langer [46] proposed a classification of 0:1- and a2 -adrenergic receptors. This classi-
fication was initially suggested on an anatom ical basis to differentiate postjunctional 
a-adrenergic receptors ( a1) and prejunctional release modulati ng receptors ( a2 ). 
The Adrencrgic Receptor Family 
I I 
a a ~ 
11 12 I 
alA alB a1c a 2A a2B a2c ~ I ~2 ~3 
Figure l. l: Adrenergic Receptor Fa m ily 
o-adre nergic receptors (01) a nd prej unct iona l release mod ula ting receptors (n2 )· 
Berthelsen and Pe t t inger [5] proposed a functiona l classification of o-adrenergic re-
ce ptors, into 01 - and 02- ad rencrgic receptors rather th an one based on anatomica l 
classificat ion. Because a natomical class ification was not re levant in all ti ssues , Drew 
a nd Whiting [15] indicated t hat ne ithe r anatomical nor funct iona l classification can 
be used as a ba::; is to classify acl rene rgic receptors . 
Now n -adrene rgic rece ptors are classified based on t heir affini t ies fo r agonists 
a nd antagonists. Differences in amagonist affini t ies a re usua lly used as a cri terion to 
classify recep tors . ,\ lpha ad rene rgic rece ptors t ha t a.re act ivated b.v eit he r mcthox-
a mine or phe nylephrinc a nd blocked in a compet iti ve ma nne r by low concen t ration 
of prazos in a re classified as cq -adrene rgic receptors [i:J] a nd o -adrene rgic r<>ceptors 
t hat are acti va ted by clonidine or medetomid ine a nd blocked by low concentrat ion of 
.voh imbine are classified as n2-adrenergir rC'ccptors. 
n 1-Adre n e r gic r eceptor subty p es 
T here is increasing ev idence from radioligancl a nd run rt iona l studies t hat n1-
adre nerg ic receptors can lw fu rt her subd ivided into two pha rmaco logica l!.\· d ist inct 
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WB4101 were resolved into two binding site models when [3H] prazosin was used as 
a radioligand [4]. T hese results were confirmed by Morrow and Creese [56] in the rat 
cerebral cortex. They formally proposed the definition of a1A- and a1 B- adrenergic 
receptor subtypes . They indicated that [3H] prazosin had similar or equal affinities 
for the two binding sites but WB41 01 and phentolamine were 20-40 t imes more po-
tent at t he a 1A-adrenergic receptor site as compare to the a 1B-adrenergic receptor 
site. T hey proposed that binding sites with subnanomolar affinity for \tVB4101 are 
a1A-adrenergic receptor subtypes whereas those with low affinity fo r WB4101 are 
alB-adrenergic receptor su btypes. 
Chlorethylclonidine (CEC ) is an irreversible alkylating derivative of clonidine 
[49]. Chlorethylclonidine has differential effectiveness at a 1-adrenergic receptors sub-
types. It has been proposed as a pharmacologi<;:al tool to di stinguish between the two 
subtypes of a 1-adrenergic receptors . Chlorethylclonidine distinguishes the two sub-
types of a -adrenergic receptors in rat liver, spleen , and vas( ductus) deferens [34]. 
Johnson and Minneman [42] demonstrated t hat CEC inactivated only approximately 
503 of the a 1-adrenergic receptors in the rat cerebral cortex but did not inactivate 
any a 1-adrenergic receptors in rat hippocampus . They confirmed th.at CEC could 
di scriminate between the two a1-adrenergic subtypes. Their results suggested that 
there are at least two pharmacologically distinct sub types of a1-adrenergic receptors 
in mammalian tissues, only one of which is inactivated by t he alkylating agent CEC. 
Thus CEC sensitive a 1-adrenergic receptors are designated as a 1B-adrenergic re-
ceptor subtypes and CEC insensitive receptors as av1-adrenergic receptor subtypes. 
Calcium ions play an important role in the regulation of many cellular processes, 
including vesicular exocytosis and muscle contraction . It is generally accep ted that 
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01 -adrenergic receptors act by increasing formation of inositol ( 114,5) trisphosphate 
(I P3) and diacylglycerol (DAG). Inositol 1,4,5-trisphosphate and diacylglycerol act 
as second messengers, the former mobilizing int racellular calcium and the latter acti-
vat ing protein kinase c [ ] . a 1 - Adrenergic receptor mediated contraction in smooth 
muscle is regulated by both intra- and extracellular calcium. Han et al. [33] indi-
cated that the two a-adrenergic receptor sub types might be linked to different in-
t racellular processes. Thus t he hypothesis has been put forward that a1 -adrenergic 
receptors subtypes may be linked to different signal t ransduction pathways . The 
a 1A-adrenergic receptor subtype has been proposed to control influx of extracellu-
lar calcium into the cell through the voltage dependent calcium ~hannels. However, 
the a 1B-adrenergic receptor subtype mediates hydrolysis of phosphatidylinositol bis-
phosphate (PIP2) to inositol l ,4,5-t ri sphosphate and diacylglycerol. This differential 
involvement of extracellular calcium in the actions of a 1A - and a 1B-adrenergic re-
ceptors has been confirmed by T sujimoto et al. [ ] while studying phosphorylase 
activation in rat hepatocytes and rabb it aorta. A similar observation has been made 
by Han et al. [33]. Their results indicate that in rat spleen . . which possess the a 1B 
-adrenergic receptor su btype, contractile responses were independent of the presence 
of extracellular calcium, whereas the rat vas deferens which contains both. the a 1A.-
and a 1s-adrenergic receptor sub type ( 40% and 60%, respectively), contrac tile re-
sponses were markedly reduced on removal of calcium. However , Klijn et al. [43] 
reported that the Dl done of Madin darby canine kidney cell line (MD C'K-Dl ), 
which is of the a 1s-adrenergic receptor subtype, mediates responses that are both 
sensiti ve to CE C and also dependent on ext racellular calcium. 
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02-Adrenergic receptors ubtypes 
That the 02-adrenergic receptor type does not represent one homogenous pop-
ulation of receptors has been indicated for many years [ 5]. A consistent pharma-
cological definition of 0:2-adrenergic receptors subtypes has resulted mainly from 
radioligand binding studies. Based on the pharmacologically determined affinity to 
the 0:2-adrenergic ·receptor antagonist yohimbine, it was suggested that there could 
be two different populations of 02-adrenergic receptors. However, these resul ts were 
obtained from two different species: rodent vs nonrodent [16]. Waterfall et a l. [91], 
while studying rat and rabbit vas deferens, indicated that the affinity of rauwolscine , 
yohimbine , and substituted benzoquinolizines was almost similar at the prejunctional 
a.2-adrenergic receptors in the rat vas deferens. However , the affinities of yohimbine 
and rauwolscine were approximately 100-fold greater than those of benzoquinolizines 
in the rabbit vas deferen s. This supports the observation of 02-adrenergic receptor 
heterogenity between species. 
While receptor heterogenity between species is important , receptor subtypes are 
usually characterized based on their heterogenity within the same species or within 
a single ti ssue . Bylund [11] suggested that 0:2-adrenergic receptor heterogeni ty does 
exist in tissues from a single species. His findings indicated that several 0:2-adrenergic 
receptor antagonists, including prazosin and oxymetazoline , had significantly differ-
ent affinities in inhibiting [3H] yohimbine binding in various regions of both rat [11] 
and human brain [66]. Thus, subclassification of 0:2-adrenergic receptors was pro-
posed based on the relative potency of prazosin [11]. Receptors having a low affinity 
for prazosin, as demonstrated in human platelet, were classified as a.2 A-adrenergic 
receptors. Whereas . receptors having a relatively higher affini ty for prazo in. as in 
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neonatal rat lung and rat kidney, were proposed to be a2B-adrenergic receptors [11]. 
A similar definition of a2 A- and a 2B·adrenergic receptor subtypes was proposed 
independently by other authors [60]. To-date there have been numerous reports 
confirming a2-adrenergic receptor heterogenity in various tissues. For instance, a2-
adrenergic receptors in rabbit spleen were shown to display a pharmacology consistent 
with a2A-adrenergic receptor subtypes while in the rat kidney a2-adrenergic recep-
tor subtypes have been reported to be of the a2B-adrenergic receptor subtype [53]. 
Furthermore, rat brain has been reported to possess both a2A- and a2 B-adrenergic 
receptor subtypes [11]. 
A third a 2-adrenergic receptor subtype has· been identified in opossum kidney 
(OK) derived cell line. This receptor subtype has a unique pharmacological profile 
which is closer to the a 2B- than to the a2A -adrenergic receptor subtype. The 
adrenergic receptor subtype which has been identified in OK derived cell line has 
high affinity for prazosin, but t he Ki (affinity) ratio of prazosin to yohimbine is 
intermediate between that of a2A- and a2B·adrenergic receptor subtype. However, 
more extensive characterization in opossum kidney cell has indicated this receptor 
subtype to be different from a2A ·and a2B-adrenergic subtypes. Thus, it has· been 
proposed that OK cells represent a third a2-adrenergic receptor subtype which has 
been designated as an a2c-adrenergic receptor subtype [58]. 
The mechanism of action for a2-adrenergic receptors is the inhibition of adenylyl 
cyclase. Unlike a1-adrenergic receptors subtypes all three a2 -adrenergic receptor 
subtypes i.e., a2A' a2B' and a2c have been shown to inhibit adenylyl cyclase [58] . 
Several ligands have been shown to possess a good degree of selectivity for 
one or the other of these a2-adrenergic receptor subtypes. Various pharmacological 
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agents have been used to subclassify a 2-adrenergic receptor subtypes. Benoxathian, 
oxymetazoline and WB4101 have been proposed to be relatively selective for a 2A-
adrenergic receptors. Prazosin, chlorpromazine and imiloxan are relatively selective 
for a2B-adrenergic receptors [53], whereas BAM1303 is relatively selective for a2c-
adrenergic receptors [12]. Although the above mentioned drugs are relatively specific 
for one or the other a2-adrenergic receptor subtypes, to-date there are no drugs which 
are exclusively selective f<;>r a given a .2-adrenergic receptor subtype. 
Classification of ,8-adrenergic re~eptors 
The concept of distinct a- and ,8-adrenergic receptors was supported by Powell 
and Slater [67]. With the discovery · of potent and selective ,B-adrenergic receptor 
agonists and antagonists , it became clear that ,8-adrenergic receptors were not ho-
mogeneous [45]. Classification of ,8-adrenergic receptors into ,81 - and ,82-adrenergic 
receptor subtype· was proposed by Lands et al. [45]. The subclassification of ,8-
adrenergic receptors into ,81 - and ,82-adrenergic receptor subtypes is now firmly es-
tablished. Now there is a strong evidence for an atypical ,B- adrenergic receptor in 
several tissues. This atypical ,8- adrenergic· receptor has been designated as a ,83-
adrenergic receptor subtype [84]. 
Unlike a 1-adrenergic receptor subtypes, the ,8-adrenergic receptor sub types do 
not use different signal transduction mechanism. All ,8-adrenergic receptor subtypes 
appear to be directly linked to the activation of adenylyl cyclase [81]. 
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CHAPTER 2. STATEMENT OF PROBLEM 
a 1- Adrenergic receptors, located in several tissues throughout the body, me-
diate rriany responses to catecholamines. An important a1 -adrenergic response is 
contraction of vascular smooth muscle. a1 -Adrenergic receptor mediated contraction 
of vascular smooth muscle plays an important role in controlling the peripheral cir-
culation. Adrenergic receptor agon ists such as phenylephrine arid norepinephrine are 
effective constrictors of human, ovine, and porcine uterine vasculature. 
Contractile responses of uterine arteries to adrenergic receptor agonist have been 
reported to be different between estrous cycle (nonpregnant day 13 , nonpregnant day 
19-21) and pregnant gilts (day 13). Furthermore, a-adrenergic receptor binding anal-
ysis, using [3H] WB4101 as a ligand, has indicated a difference in binding between 
est rous cycle and early pregnant gilts. However , no detailed functional pharmacologi-
cal characterization of uterine vasculature adrenergic receptors between nonpregnant 
and various stages of pregnancy in e.ither gilts or sows has been reported. 
T he purpose of this study was as follows: 
1) To pharmacologically characterize the a -adrenergic receptors of the isolated 
porcine uterine artery in t he luteal and, follicular phase and in early pregnancy and; 
2)To ascertain the functionality of various disposition mechanisms for nore-
pinephrine in the arterial wall by determining the magnitude of norepinephrine po-
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tentiation in response to inhibition of uptake-1 , uptake-2, monoamine oxidase, and 
catechol-o-methyl transferase. 
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CHAPTER 3. MATERIALS AND METHODS 
General Considerations 
Sp.ecimens of uterine arteries were obtained from pigs in estrous cycle (luteal 
phase and follicular phase), and in early pregnancy (approx. 40-45 days). The 
crown-rump measurement [19] was done in order to determine the day of pregnancy. 
The crown-rump measurement is the distance between the highest point of the head 
and the base of the tail. The difference between the luteal phase and follicular phase 
of the estrous cycle was made based on the presence (luteal phase) or the absence (fol-
licular phase) of the corpus luteum. Specimens were collected from the Iowa Packing 
Plant in Des Moines. Immediately after collection, the tissues were placed in an ice 
cold modified Krebs solution of the following composition (mM): NaCl, 115.21 ; KCl , 
4.70; CaCl2, 1.80; MgS04, 1.16; KH2P.04, 1.1 ; NaHC03, 22.14; dextrose, 7. 8; 
EDTA ( disodium ethylenediamine tetraacetic acid 0.03mM ), indomethacin (lo - 6M 
and aerated with air. The tissues were then t ransported to the laboratory. EDTA 
was added to suppress the oxidation of amines and indomethacin was added to inhibit 
prostaglandin synthesis. 
The (middle) uterine artery supplying one uterine horn was separated from sur-
rounding tissues. Tissues not used immediately were stored upto 24 hours at 4° C in 
Krebs solution which was continuously oxygenated with a (95:5) oxygen and carbon 
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dioxide mixture. Isolated arterial ri ngs of about .Smm were prepared from the (mid-
dle) u teri ne artery before the first bifurcation . Two stainless steel hooks were passed 
through t he vessel lumen [3 ] . One hook was attached to the the base of the bath 
and the other was attached to the Grass force t ransducer FT03 which was in turn 
connected to a Beckman R-611 channel chart recorder. Tissue contractions were 
recorded isometrically. The ring segments were suspended in lOml isolated organ 
baths. maintained at 37° C, bathed with a Krebs solution and aerated continuously 
with a oxygen- carbon dioxide (95 :5) mixture. The ring segments were initially equi-
librated for 30 minutes under no tension. The tissues were then placed under, 4g 
tension for 30 minutes period [75]. The ring segments were then brought to a resti ng 
tension of 2g and were further equilibrated for 60 minutes with regular replacement of 
bath fluid at 15 minute intervals. Tiss ues were maintained at 2g tension throughou t 
the experiment. 
Determinat ion of t he D issociat ion Constant (KB) 
Uterine ring segments from the same uterine a rtery were prepared and suspended 
in Krebs solution. Iproniazid (0.36 mM ) was added to the bath for 60 minutes and 
then washed for 40 minute at 10 minute intervals. Cocaine (lo-·5M), tropolone 
( 10- 5M), propranolol (lo -6M ), and cor ticosterone acetate (lo-6M), were added 
for 20 minutes and t he concentration-response relationship to phenylephrine was ob-
tained in the presence of these drugs. lproniazid was added to block monoamine 
oxidase while cocaine and corticosterone were used to block uptake mechanisms. 
Tropolone was added to inhibit CO IT and propranolol to block ,B-adrenergic re-
ceptors. A first concentration-response relationship to phenylephrine was obtained 
1 
following the cumulative addition of phenylephrine in approximate ly one-half log in-
crements [ 9]. After complet ion of the first concentration-response relationship, t he 
tissue baths were washed for 60 minutes at 15 minute intervals. Three different 
concentrations of prazosin (3 x 10- 9, 10 - , and 3 x 10-8 M) were added to the 
tissue baths and were allowed to equilibrate for 60 minutes . A second concentration-
response relationship to phenylephrine was obtained in the presence of prazosin. A 
ring segment prepared from the same uterine artery which received no antagonist was 
used as a "time control", and was used to correct for any changes in tissue sensitivity 
during the course of the experiment. · 
The shift of the log concentration-response relationship to phenylephrine in the 
presence and in the absence of prazosin was determined at the EC50. This shift is 
referred to as the concentration ratio (CR ). Any shift in the phenylephrine response 
curve with time (CRT )= (EC50 at time t / EC50 at time 0) was used to correct 
the concentration-ratio obtained for antagonist (CR )= (EC50 in the presence of 
antagonist / EC50 in the absence of antagonist ) according to the formula: 
Adjusted C R = C R / C RT 
These adjusted concentration ratios were used to calculate the dissociation con-
stant of prazosin. Prazosin dissociation constant was calculated by the method of 
the Schild as described by Furchgott [27]. From the plot of log(CR-1) against log [B], 
KB was calculated by using the equation: 
log( C R - 1) = log [B ] - logK B 
where CR is the concentration ratio , which is the ratio of concent ration of agonist 
giving an equal response in the presence and in the absence of antagonist, and [BJ 
is the concentration of the antagonist. If the blockade is compet itive, a plot of the 
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logarithm of (C'R-1) against the negative logarithm of the molar concentration of 
antagonist should yield a straight line whose slope is - 1 and the intercept along the 
abscissa is the pA2 value, which is equal to - logK B· Under equilibrium conditions: 
pA2 = -logK B 
where pA2 is the negative logarithm of the concentration of the antagonist re-
quired to give a dose ratio of 2, and J( B is a quantitative measure of the dissociation 
of the receptor-antagonist complex. 
An alternate method was used to determine the apparent dissociation constant( KB ) 
for WB4101. Cterine ring segments were treated with inhibitors for uptake-I and 
upta~e-2 as well as for MAO and COMT and a first concentration-response relation-
ship to norepinephrine was obtained as described in section entitled "Determination 
of the Dissociation Constant". After comp let~on of the first concentrat ion-response 
relationship, the tissue baths were washed for 60 minutes at 15 minute intervals. In 
order to determine the apparent di ssociation constant (KB) for WB4101 a single 
concentration (10 - M) of antagonist WB4101 was used. WB4101 (10 - :VI ) was 
added to the one tiss ue bath and was equilibrated with the tissue for 60 minutes . A 
tissue which received no antagonist was used as a "time control". A norepinephrine 
concentration-response relationship was then repeated in the presence of antagonist. 
The apparent dissociation constant J( B for the antagonist was calculated by using 
the following formula: 
Apparent KB =[antagonist]/(CR-1) 
where [antagonist ] represents the molar concentration of the antagonist and the 
concentration ratio (CR ) is calculated as above ( EC,5 0 of the. agonist in the presence 
of the antagonist divided by the control EC50)· 
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D etermination of the Agonist Dissociation Constant (KA) for 
Phenylephrine 
Ring segments of uterine artery were prepared and suspended in Krebs solution 
as described in t he section entitled "General Considerations". Ring segments were 
pretreated with iproniazid (0.36mM). Cocaine (10- 5M), corticosterone (10-6 M), 
tropolone (10- 5 ~1 ), and propranolol (10 - 6M) were added for 20 minutes before 
starting the concentration- response relationship to phenylephrine. A concentration-
response relationship to phenylephrine was obtained by the cumulat ive addition of 
phenylephrine in approximately one-half log increments to the bath [ 9]. After com-
pletion of the first concentration-response relationship to phenylephrine t he tissues 
were washed for 60 minutes at 15 minute intervals. Dibenamine in the following 
concentrations was used to inactivate a fraction of the receptors: (6 x 10 - 61\II) in the 
luteal phase, (7.5- .0 x l0- 7M) in the follicular phase and (7.5 x 10- 7 - 1x10- 61\II ) 
in early pregnancy. Di benamine was added to the tissue bath for a 20 minute period 
to inactivate the a-receptors. The tissue baths were then washed 5-6 ti mes over 30 
minutes. A second concentration-response to phenylephrine ·was then obtained. To 
obtain the K A values , an analysis of the plotted concentration response data was 
made as desc ribed by Furchgott and Bursztyn [26]. Equieffective concentrations of 
phenylephrine before [A] and after [A1] partial receptor inactivation were obtained 
from the concent ration-response curves and a plot of 1/ A versus 1/ A1 was ·generated. 
The slope of the regression line and the Y-intercept were used to calculate KA using 
the equation: 
l /[A] = (1 - q) / qKA + l / q[A' ] 
where q is the fraction of active receptors remaining after irreversible inacti vation. 
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Hence, 
K A = slope - I / inter cept 
D et ermination of 0:1-Adrenergic R eceptor Subtypes in P o rcine Uterine 
Artery 
Uterine ring segments from the same uteri ne ar tery were prepared and suspended 
in Krebs solution as described in the section enti t led "General Considerations". In 
brief, ring segments were pretreated wi th iproniazid (0.36mM) for 60 minutes. The 
t issues were then washed for 4-5 times over 40 minutes. Cocaine (lo-·5M). corticos-
terone (lo- 6M), t ropolone (lo- 5M), and propranolol (lo - 6M ) were added to the 
ti ssue baths fo r 20 minutes before starting the initial concentra tion- response rela-
tionship to norepinephrine. To one tissue bath, nifedip ine {lo - 6M) was added for 20 
minutes and a second concentration-response relationship to NE was generated in the 
presence of nifedipine. A paired "time control" was run which received no nifedipine. 
Experiments in which nifedipine was used were carried out in a darkened room. To 
the another ti ssue bath the irreversible !ilkylating agent chlorethylclonidine (CEC) 
(5 x 10- 5 M ) was added for 30 minutes . The tissue bath was then washed 5-6 times 
over a 40 minute interval . A second concent ration-response relationship to NE was 
then obtained. A paired "time control" t issue in each experiment was used to correct 
for time-dependent ch anges in agonist sensitivity. 
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Analysis of Disp osi t ion Mecha nism s for Nor epine phrine 
In our experiments we used blockers for neuronal uptake and extraneuronal up-
take as well as inhibitors of MAO and CO MT to study disposition mechanisms in 
ring segments of uterine artery The degree of potentiation i .e., the potentiation factor, 
obtained for norepinephrine produced by blockers and inhibitors of these disposit ion 
mechanisms was used as an index of that mechanism in the metabolism of nore-
pinephrine. 
Six uterine ring segments from the same uterine artery were prepared and mounted 
in organ baths containing Krebs solution. The ring segments of uterine artery were 
equilibrated as described above in section "General Considerations'' . An initial 
concent ration-response relationship to norepinephrine was obtained by the cumula-
tive addition of norepinephrine in approximately one-half log increments . The ti ssue 
baths were then washed 4-5 times at 15 minute intervals, during which time the tis-
sues relaxed and control tensions were achieved. The six ring segments (tissues) were 
then treated as follows: 
(1) Cocaine (lo- 5M), an uptake-1 blocker , was added to· this t issue bath for 20 
minutes. This was followed by a second concentration-response relationship to 
norepinephrine. This will allow us to assess the role that neuronal uptake has 
in the response to norepinephrine; 
( 2 ) Corticosterone (10 - 51\1 ), an uptake-2 blocker was added to thi s t issue bath for 
a period of 20 minutes . As in tissue 1 above, this was followed by a second 
concentration-response relationship to norepinephrine . This will allow us to 
assess the role of extra-neuronal uptake; 
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(3) Tropolone (lo-·5 I ) was added to this tissue bath for a period of 20 minutes . 
As in the t issues above , this was followed by a second concentration-response 
relationship to norepinephrine. This will allow us to assess the importance of 
COMT; 
( 4) This tissue bath was treated exactly the same way as the three tissues described 
above, except that no drug was added to it . It was used as a "time control" 
for the above three tissues in order to correct for any t ime-dependent changes 
in t he tissue's sensitivi ty to norepinephrine during the experiment; 
( 5) To ascertain the involvement of monoamine oxidase, in the disp osition of nore-
pinephrine, iproniazid (0.36mM) was added to this tissue bath for 60 minutes. 
The ti ssue bath was then washed 5-6 times over a 40 minute period and a 
second concentration-response relationship to norepinephrine was generated; 
(6) This tissue was t reated exactly the same way as tissue 5 described above, except 
t hat no drug was added to it. It was used as a "time control ' for tissue 5. 
For each individual, drug i.e., cocaine, corticosterone , tropolone , and iproniazid, 
the analysis of the data was performed as follows: Effective concentration ( EC.50 )i in 
the absence of above mentioned drugs was obtained from their concentration-response 
curve to norepinephrine. Similarly, ( E C50 )2 to norepinephrine in the presence of 
these drugs was obtained from i ts concentration-response curve. The shift in the 
norepinephrine concentration-response curve with time was calculated using the for-
mula (C RT = EC50 at time t / EC50 at time 0) as di scussed in the ection entitled 
·'Determination of the Dissociation Constant ( KB )" . The concentration ratio C' RT 
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was used to obtain the corrected ( EC.50 )2 in the presence of drug using the formula 
below: 
corrected (EC50) = (EC'50 )2 / C Ry. 
The potentiation factor ( P . F.) was calculated using the formula: 
P. F = corrected (EC50 )2 / (EC5oh· 
Statistical Analysis 
In order to analyze the data obtained for the determination of the dis sociation 
constant for prazosin, phenylephrine, and WB4101 we used analysis of variance. The 
data -0btained for the subclassification of a 1-adrenergic recept.ors subtypes and for 
the disposition study were analyzed by using the Student t-test. 
Drugs 
The following drugs were used : phenylephrine HCI USP (Winthrop Labora-
tories); prazosin HCl and nifedipine (Pfizer Inc.); iproniazid phosphate (Hoffman-
LaRoche ); tropolone (Aldrich Chemical Company ); propranolol HCl ( Ayrest Labora-
tories Inc. ); cocaine, indomethacin. [-] norepinephrine, and corticosterone 21-acetate 
(Sigma Chemical Company ); dibenamine HCl (Smith, Kline & French); chlorethyl-
clonidine (Research Biochemicals Incorporated); WB4101 (Dr. W. L. Nelson, Uni-
versity of Washington) . Medetomidine HCl (Farmos Group Ltd.) All the drugs were 
dissolved in saline except corticosterone, indomet hacin, dibenamine and nifedipine 
which were dissolved in ethanol. 
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CHAPTER 4. RESULTS 
Phenylephrine produced concentration-dependent contractions of porcine uter-
me artery during the luteal phase, follicular phase and in early pregnancy stages. 
Prazosin an 01-adrenergic receptor antagonist, competitively inhibited responses to 
phenylephrine in the luteal phase, follicular phase as well as in early pregnancy. Max-
imum responses to phenylephrine were not affected by prazosin ( 3 xl0-9, 10- , 3 
x 10- M ) (Figures 4.1, 4.2 and 4.3). Schild plots (Figures 4.4, 4.5, and 4.6) for 
prazosin vs phenylephrine yield straight line during the luteal phase, follicular phase 
and early pregnancy with slopes not significantly different from unity. The pA2 val-
ues obtained in the luteal phase, in the follicular phase and in the early pregnancy 
were 8.98, 9.04, and 9.10 respectively. These pA2 values are not significantly different 
from each other (P > 0.05 ). The dissociation constant (KB ) was found to be 10.4 
x 10- lOM, 9.1 x 10-lOM, and 7.9 x 10- lOM in the luteal phase, in the follicular 
phase and in early pregnancy stages, respectively. 
In order to ascertain the contribution that 02-adrenergic receptors may have 
in mediating contractile responses to norepinephrine, the 02-adrenergic receptor ag-
onist medetomidine was used. Medetomidine did not produce any significant con-
traction. The threshhold response for contraction to medetomidine was observed at 
the concentration of 3 x 10-7_10- 6M and the maximum response to medetomidine 
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was observed at a concentration of 10-·5M. The maximum response obtained (to 
10 - 5M ) of medetomidine was 183 relative to the initial response to phenylephrine. 
(N = 4,results not shown). 
An example of the experiment to determine the KA for phenylephrine is pre-
sented in Figure 4. 7. Dibenamine reduced the maximal response to phenylephrine 
about 403 -603 in the luteal phase, in the follicular phase the response was reduced 
by 253-753 and in the early pregnancy maximal response was reduced by 503 -753 . 
The mean dissociation constant (KA ) for phenylephrine was found to be 6.5 ± 1.8 x 
10-6M.in luteal phase, 3.7 ± 0.7 x 10- 6M in follicular phase and 4.4 ± 1.7 x 10- 6M 
in early pregnancy. These KA values are not significantly different from each other(P 
> 0.05). 
Norepinephrine produced concentration-dependent contractions in isolated uter-
ine artery during the luteal phase, follicular phase, and in early pregnancy stages . The 
putative selective a 1A-adrenergic antagonist WB4101 (lo - 8M) inhibited responses 
to norepinephrine in the luteal phase, follicular phase and in early pregnancy (Fig-
ures 4.8, 4.9, and 4.10). The dissociation constant (Ks ) in the luteal phase, follicular 
phase and in early pregnancy was found to be 11.7 x 10-lOM, 1.69 x 10-lOM. 5.4 
x 10- 10M, respectively. These KB values are not significantly different from each 
other (P > 0.05 ). 
The selective irreversible a 1B -adrene!gic antagonist CEC (lo - 5M) displaced 
the norepinephrine concentration-response relationship curve to the right and also 
significantly depressed the maximum response to norepinephrine in the luteal phase, 
follicular phase and in early pregnancy (Figures 4.11 , 4.12, and 4.13) . The percent 
maximal reduction to norepinephrine in the presence of CEC was 44% in the luteal 
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phase, 30.53 in the fo llicular phase, and 413 in early pregnancy. 
The calcium channel antagonist nifedipine (10 - 6M) shifted the concent ration-
response curve to norepinephrine to the right in the lu teal phase, follicular phase, and 
in early pregnancy. However , the shift was significant only in the follicular phase. 
T he maximum contracti le response to norepinephrine was reduced by 26.13 in the 
luteal phase, 41.53 in the follicular phase, and 16.43 in early pregnancy by nifedipine 
(Figures 4.14 , 4.15 , and 4.16 ). 
Table 4.1: The potentiation of responses to NE by drugs 
which influence its disposition 
Pregnancy stage Drug Potentiating Factor 
luteal phase Iproniazid 1.1.5± .17a 
Cocaine .3 ± .05 b 
Corticosterone .23± .04 b 
Tropolone 1.0± .21 a 
Follicula r phase Iproniazid . 76 ± .07 a 
Cocaine .37 ± .05 b 
Corti cos terone .48 ± .14 b 
Tropolone .99 ± .23 a 
Early pregnancy lproniazid .94 ± .36 a 
Cocaine .47 ± .10 b 
Corti cos terone 
. b 
.41 ± .08 
Tropolone 1.1 I .23 a 
asuperscript not different from 1 (P > 0.05) 
6Superscript different from 1 (P < 0.01 ) 
The potentiation factor obtained for iproniazid , (Figures 4.17. 4.18, and 4.19), 
was not significant ly different from unity in the luteal phase, fo llicular phase and in 
early pregnant pigs (P > 0.05) . Results are summarized in (Table 4.1). Similar re-
sults were obtained with t ropolone where the potentiation factor was not significantly 
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different from unity in the luteal phase follicular phase and in early pregnancy (P 
> 0.05 ). Results are summarized in (Table 4.1 ). However , the potentiation factor 
obtained for cocaine was significantly different from unity in the luteal phase, follic-
ular phase and in early pregnancy (P < 0.01 ) The potentiation factor obtained for 
corticosterone in the luteal phase , follicular phase and in early pregnancy was signif-
icantly different by unity (Figures 4.20, 4.21, and 4.22) (P < 0.01 ). Ethanol(20 µl ) 
did not have any effect ori norepinephrine- induced contractions . (P > 0.05, Figure 
4.23). 
Figure 4.1. C umulative concentration-response curves for phe~1y lephrine (PE) !.)btained 011 isolated rings of 
porcine ute rine artery in the luteal ph ase before and afte r equilibration for 60 minutes in the 
presence of prazos in (3 xl0- 9 , 1 x 10- 8 , a nd 3 x 10- 8 M ).· Each point repr~sents the mean :L S.E 
of tissues from 6 animals a nd is expressed as a pe rcentage of the control cont raction obtained to 
pheny lephri ne ( 3 x 10- 6 M). 
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Figure 4.4. Schild plot for <lc t errni11atio11 o f the p /12 for pra.zos 111 when tested against phe nyl e phrine o n iso-
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Fig ure 4.5. Schil<l plot for <ldcrmination of the p.r-1 2 for prazosin when teste<l against phenyl e phrine o n isolated 
rings of porcine uterine artery in the follicular phase. Each point represents the mean of six 
experime nts. The inte rcept on the abscissa gives the pA2 value. T he slope of the fitted regression 
line is shown in the figure. 
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Figure 4.7. An example of the e ffect o f treatme nt with dibe na.mine on phcny le phrine elicited contractio n!> o n 
i::.olate<l rings of porci11e ute rin e a rte ry in the folli cular ph ase. Contractions to phenylephrine were 
o bta ined before a.n<l after exposure to (7.5 x JO 7 M o f <libc na111i11 e) for 20 minutes. Dibe na111ine was 
was he<l o ut o f th e tiss ues be fore obtaining th.e ::.econd co ncentra.tion- relationship to phe ny leph rin c. 
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C H A P T ER 5. DISCUSSI ON 
D eter m ination of the Dissociation Constan t for Prazosin 
In our study we have classified a1 -adrenergic receptors in isolated porcine uter-
ine artery in the luteal phase, follicular phase and in early pregnancy, on the basis 
of their sensit ivity to phenylephrine, a selective a1-adrenergic receptor agonist, and 
prazosin, a selective a1-adrenergic receptor antagonist . Selective antagonists are 
widely used to classify receptors because a single property, affinity, governs their 
interaction with the receptor [44]. Prazosin is generally accepted as a potent and 
highly selective antagonist of 01 -adrenergic receptors. In our studies prazosin shifted 
the concentration-response curve for phenylephrine during the luteal phase, fo llicular 
phase and in early pregnancy stages to the right in a parallel manner without de-
pressing the maximal response , indicating competi tive inhibition. Furthermore, the 
slope of t he child plot was not signi~cantly different from unity thu indicating that 
the antagonism is competitive. The pA scale as described by Schild [77] is used to 
measure antago nist affinity. The pA2 value for prazosin was found to be .9 in the 
luteal phase. 9.04 in the follicular phase and 9.10 in the early pregnancy. These values 
indicate a high affinity of prazosin for a 1 -adrenergic receptors in the isolated porcine 
uterine arte ry during the lu teal phase, follicular phase, and in early pregnancy. Since 
antagonists bind to the receptor but do not activate it, the pA2 value for an antag-
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onist in blocking the response to an agonist should be an accurate indication of it' s 
affini ty in binding to the receptor [44]. The dissociation constant of prazosin at a1-
adrenergic receptors is typically between 1 and lOnM [73]. The dissociation constant 
in this study was found to be in the acceptable range. Prazosin was also found to be 
highly potent(K i=l.lOnM) in competing fo r uterine arterial binding d uring estrous 
cycle and early pregnant gilts [70]. The pA2 values for prazosin obtained in this study 
correlate well with the pA2 values obtained in the other vascular smooth muscle [2], 
[39]. Agarwal et al. [2] reported that there is a 100 -fold range in prazosin affinity for 
a-adrenergic receptors. pA2 Values for prazosin obtained in porcine uterine ar tery 
in three different stages of the reproductive cycle are not signific~nt ly different (p > 
0.05 ). This finding provides evidence that phenylephrine produces contraction of the 
uterine artery in these three di fferent phases by acting on the same type of receptor. 
D e t ermination of the Agonis t Dissociation Constant 
The validi ty of the determination of KA undertaken for phenylephrine depends 
on the acceptan ce of the theroetical assumptions of receptor agonist interactions 
following irreversible recep tor inactivation as outlined by Furchgott and Bursztyn 
[26]. KA fo r phenylephrine in the late pregnant ovine uterine artery is reported to 
be 2.5 x 10- 6 M [39]. In our present study we obtained a mean KA value of 6.5 ± 
1. x 10 - 6M in t he luteal phase, a K .4 value of 3.7 :t: 0. 7 x 10 - 6M in the follicular 
phase and a KA value of 4.4 :::: 1.7 x 10-6M in early pregnancy. The KA rnlues in 
the present study compare favorably with the values obtained in ovine late pregnant 
uterine artery, indicating that the same type of a-adrenergic receptors mediate t he 
cont ractile response in ovine and porcine uterine artery. The resul ts obtained in 
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t he present st udy indicate that although di fferent concentrations of dibenamine were 
required to inactivate a fraction of the receptors in the luteal phase, follicular phase 
and early pregnancy, the affinity of t he agonist was the same in all t hree stages. 
Involvem ent of 0:2-Adren ergic R ecep tors 
The porcine u terine artery has been reported to possess both 0:1-and 0:2-adrenergic 
receptors [32]. The contractile response to 0:2-adrenergic receptor activation has been 
demonstrated in a few resist ance vessels [63]. However , in our present study, medeto-
midine a selective 0:2-adrenergic agonist fai led to produce any significant contractile 
response. The possible reason for the lack of a signifi cant cont ract ile response is that 
the signal transduction pathways that are normally activated by 0:2- adrenergic re-
ceptors are not present [61]. Ford et al. [24], using an in vitro perfusion technique, 
have shown in the pig uterine artery from pregnancy that 0:2-adrenergic receptors 
are involved in maintaining tone rather than in evoking the contraction. 
The results obtained in our present study are comparable with that obtained in 
the rabbit uterus . Rabbit uterus contains both cq -and a2-adrenergic receptors but 
the contractile response observed is due tp 0:1-adrenergic receptors with no functional 
response resulting from act ivating a 2-adrenergic receptors [37]. 
Subclassification of a: 1-Adrene rgic R eceptors 
T he proposed subclassification by Minneman [54] of a1 -adrenergic receptors into 
0:1 A- and 0:1 s - adrenergic receptor sub types is based on sensitivity to selective an-
tagonists, such as CEC', WB4101, and dependency on extracellular calcium. It has 
been indicated t hat the a 1s -adrenergic receptor subtype is selectively u ceptible to 
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CEC and is less sensitive to WB4101. The a 1A-adrenergic receptor subtype is more 
sensitive to \,YB4101 and is less suscep tible to CEC. Thus, WB4101 has been indi-
cated to interact differently with CEC sensitive and CEC insensitive a 1 -adrenergic 
receptor subtypes. 
We have attempted to sub classify a i -adrenergic receptors in porcine uterine 
artery in the luteal phase, follicular phase and in early pregnancy. Our results show 
t ha t norepinephrine caused dose-dependent contractions of porcine uterine artery 
during the estrous cycle and in early pregnant pigs. WB4101 , an a 1A select ive 
antagonis t . inhibi ted uterine artery responses to norepinephrine during est rous cycle 
and in early pregnancy. The KB for WB4101 in-thi s study of uterine artery during 
estrous cycle and in early pregnancy stages correlate wit h the values reported in other 
tissues, like renal and mesenteric arteries ot rat [35] and rat aorta [65]. Based on the 
affinity to WB4101 , contractile responses to norepinephrine in this present study are 
mediated by a 1A- adrenergic receptors. 
It has been suggested that 01-adrenergic receptor subtypes respond differently to 
CEC, and thus CE C can be an important pharmacological tool in sub classifying 01-
adrenergic receptors. In this study pretreatment with CE C ·5 x 10- 5 M shifted the 
concentration-response curve to norepinephrine to the right. and reduced the maximal 
response. These results indicate that arterial rings of porcine uterine artery during 
the estrous cycle and early pregnancy are sensitive to a proposed o 1B -adrenergic 
receptor antagonist , CEC. Increasing the concentration of CEC to 1x10- 4M did not 
suppress t he maximal response to norepinephrine any further than did 5 x: 10 - 5 ~1. 
Chlorethylclonidine has been used to di scriminate the two receptor subtypes by many 
authors. For example, CEC 5 x 10- .5 ~I had no effect on norepinephrine induced 
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contract ions of the dog mesenteri c artery while the same concentration of CEC shifted 
the norepinephrine dose-response curve in t he dog carotid artery to t he right [57]. 
Studies from radioligand binding by Eugenia et al. [18] also suggest that CEC is 
more sensitive in tissues where the a1 B -adrenergic receptor subtype is predominant, 
as compared to the a1 A-adrenergic receptor su btype. It has been indicated by these 
authors [18] t hat CEC inactivated different proportions of a 1-adrenergic receptor in 
rat liver cells and rabbit ~orta . In rat liver cells (which possess predominantly a 1s-
adrenergic receptors) 70%-803 of a 1-adrenergic receptors were inhibited by CEC. 
Whereas , rabbit aorta (which possess predominantly a 1A-adrenergic receptors ) only 
30%-40% of a1-adrenergic receptors were inhibited by CEC . Based on the sensitivity 
to CEC in our present study on the porcine uteri ne arterial rings, our results indicate 
the presence of a 1B-adrenergic receptor subtype. 
The literature to-date suggests that a1-adrenergic receptor subtypes utilize dif-
ferent sources of ·calcium. The a 1A-sub type has been suggested to be dependent on 
ext racellular calcium in mediating t he contractile response, whereas the a 1B-subtype 
causes the release of intracellular calcium . In thi s st udy nifedipine (a calcium channel 
blocker) significantly shifted the concent ration-response curve to norepinephrine to 
the right only in the follicular phase. The maximum response to norepinephrine in 
the presence of nifedipine was depressed significantly in the luteal phase, follicular 
phase, and in early pregnancy stages. T his observation suggests t hat the cont rac tile 
response to norepinephrine is not totally dependent on extracellular calcium. These 
findings indicate that the contractile response to norepinephri ne is not mediated by a 
single receptor, but by a mixture of recep tors . The results presented here suggest that 
both ai.,.1-and a1B- adrenergic receptor subtypes exist in pig uteri ne artery during 
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estrous cycle and in early pregnancy stages. Similar observations have been obtained 
in other tissues which are known to contain both subtypes, such as the portal vein 
and mesenteric artery of the rat [35]. 
Analysis of Dis p osition Mechanism for Norepinephrine 
The MAO inhibitor iproniazid did not produce any significant change in the 
concen~ration- response relationship to norepinephrine. The potentiating factor ob-
tained for iproniazid a MAO inhi·bitor was not significantly different from unity (p > 
0.05 ) , suggesting that this enzyme does not have an important role in the uterine 
artery during the estrous cycle and early pregnancy for terminating the action of 
norepinephrine. Similar observaions have been made by Griesemer et al. [30] who 
indicated that inhibition of MAO wit h iproniazid did not potentiate the actions of 
exogenous noradrenaline on the cat nicitating membrane. Furthermore, Hertting and 
Axelrod [36] reported that MAO seems to be of little importance in the metabolism 
of 3 H-noradrenaline after the release of the labelled catecholamine from sympathetic 
nerve endings following sympathetic nerve stimulation. Thus , there is little evidence 
from our experiments or from the literature that MAO is an important mode of 
disposition for norepinephrine in th<: blood vessel wall. 
The role of COMT in our present study was assessed by the abili ty of tropolone to 
modify the contraction to norepinephrine. The COMT inhibitor , tropolone , did not 
produce any significant change in the concentration-response relationship (p > 0.05) 
to norepinephrine. The potentiating effect of tropolone on the catecholamine (nore-
pinephrine, epinephrine, and a- methylnorepinephrine)-response of rat aorti c strip 
has been demonstrated [.51 ]. The potentiating factor obtained for tropolone in the 
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present study was not significantly different from unity. Thus, our results suggest 
that CO YIT does not represent an important mode of disposition for norepinephrine 
in porcine uterine artery. 
The neuronal uptake (uptake-!) inhibitor cocaine in this study made a signifi-
cant change in the concentration-response relationship to norepinephrine in the luteal 
phase, follicular phase as well as in the early pregnant porcine uterine artery (p< 
0.01 ). The potentiating factor for cocaine was significant ly different from unity sug-
gesting the importance of uptake-1 in the porcine uterine artery. Cocaine has also 
been reported to potentiate the response to norepinephrine on the rabbit aorta [25]. 
Cocaine has also been reported to increase the sensi tivity to nor.epinephrine in the 
rat at ria [59]. It has been suggested that cocaine potentiates t he response to nore-
pinephrine at least in part by blocking neuronal uptake. 
Extraneuronal uptake is a process which involves the removal of the transmitter 
from the a-adrenergic receptor region. The importance of extraneuronal uptake is 
suggested by the magnitude of the potentiation of the response of arteries to nore-
pinephrine after blockade of this uptake system. In this stuqy we observed that the 
uptake-2 blocker corti costerone produced a significant change in the concentration-
response relationship to norepinephrine during the estrous cycle and in early preg-
nancy stages (p< 0.01 ). The potentiating factor obtained for corticosterone was 
significantly different from unity. Thus, our result s indicate that both uptake-1 and 
uptake-2 play an important role in the di sposition of norepinephrine in the wall of 
the porcine uterine artery in the estrous cycle and in early pregnancy stages. Extra-
neuronal uptake has also been identified in t rachealis smooth muscle cells of cat and 
rat and in the dog coronary artery '.64], as well as in a a cell line derived from cancer 
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cells of human renal tubules (Caki- cells) [76]. 
In summary, our results indicate that there is no difference in the affinity of either 
prazosin or phenylephrine for t he a-adrenergic receptor in the porcine uterine artery 
in the luteal phase, folli cula r phase, and in early pregnancy. The results also indicate 
the presence of both the a1A- and a 1s-adrenergic receptor subtypes in the lu teal 
phase, follicular phase and in early pregnancy. Based on the results obtained from 
the study of disposition mechanisms, we conclude that both uptake-1 and uptake-2 
play an important role in reducing the concentration of no repinephr ine at the a 1-
adrenergic receptor in t he porcine uterine artery in the lu teal phase, follicula r phase 
and in early pregnancy. 
For future work , we suggest the use of radioligand binding assays to determine 
which a-adrenergic receptor subtype is predominant in the porci ne uterine artery. 
Also, we suggest extending our studies to other stages of pregnancy, including mid-
pregnancy and late pregnancy stages. 
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